Endemic mycoses: A treatment update

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 3, 1999, Pages 321-331

  Lortholary, Olivier ^a   Denning, David W ^b   Dupont, Bertrand ^c  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; COCCIDIOIDOMYCOSIS; ENDEMIC DISEASE; HISTOPLASMA; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LONG TERM CARE; MYCOSIS; PENICILLIUM MARNEFFEI; PROPHYLAXIS; PUBLIC HEALTH; REVIEW; SOUTH AMERICAN BLASTOMYCOSIS; SPOROTRICHOSIS;

EID: 0033061187     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.3.321     Document Type: Review

References (88)

1. Ampel, N. M. (1996). Emerging disease issues and fungal pathogens associated with HIV infection. Emerging Infectious Diseases 2, 109-16.
2. Cunliffe, N. A. & Denning, D. W. (1995). Uncommon invasive mycoses in AIDS. AIDS 9, 411-20.
3. Lortholary, O., Guillevin, L. & Dupont, B. (1995). Les mycoses invasives rares au cours du SIDA. In Le Traitement des Mycoses Systémiques (Vachon, F., Yeni, P., Coulaud, J. P., Vildé, J. L. & Pocidalo, J. J., Eds), pp. 75-86. Journées de l'Hôpital Claude-Bernard, Librairie Arnette, Paris.
4. Lortholary, O., Guillevin, L., Dupont, B. & Drouhet, E. (1995). Treatment of histoplasmosis and coccidioidomycosis. Médecine et Maladies Infectieuses 25, special issue, 63-73.
5. Kauffman, C. A. (1994). Newer developments in therapy for endemic mycoses. Clinical Infectious Diseases 19, Suppl. 1, S28-32.
6. Goldman, M. (1994). Histoplasmosis: a treatment update. Current Opinion in Infectious Diseases 7, 667-70.
7. McKinsey, D. S., Kauffman, C. A., Pappas, P. G., Cloud, G. A., Girard, W. M., Sharkey, P. K. et al. (1996). Fluconazole therapy for histoplasmosis. Clinical Infectious Diseases 23, 996-1001.
8. National Institute of Allergy and Infectious Diseases Mycoses Study Group. (1985). Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. Annals of Internal Medicine 103, 861-72.
9. Slama, T. G. (1983). Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. American Journal of Medicine 74, Suppl. B, 70-3.
10. Mangino, J. E. & Pappas, P. G. (1995). Itraconazole for the treatment of histoplasmosis and blastomycosis. International Journal of Antimicrobial Agents 5, 219-25.
11. Dismukes, W. E., Bradsher, R. W., Cloud, G. C., Kauffman, C. A., Chapman, S. W., George, R. B. et al. (1992). Itraconazole therapy for blastomycosis and histoplasmosis. American Journal of Medicine 92, 489-97.
12. Maholtz, M. S., Dauber, J. H. & Yousem, S. A. (1994). Case report: fluconazole therapy in histoplasma mediastinal granuloma. American Journal of the Medical Sciences 307, 274-7.
13. Pappas, P. G., Kauffman, C. A., Perfect, J., Johnson, P. C., Mckinsey, D. S., Bamberger, D. M. et al. (1995). Alopecia associated with fluconazole therapy. Annals of Internal Medicine 123, 354-7.
14. Graybill, J. R. & Bocanegra, R. (1995). Liposomal amphotericin B therapy of murine histoplasmosis. Antimicrobial Agents and Chemotherapy 39, 1885-7.
15. Harten, P., Baron, Y. & Euler, H. H. (1995). Lipsomal amphotericin B therapy in disseminated histoplasmosis. Archives of Internal Medicine 155, 1556.
16. Tobon, A. M., Franco, L., Espinal, D., Gomez, I., Arango, M., Trujillo, H. et al. (1996). Disseminated histoplasmosis in children. The role of itraconazole therapy. Pediatric Infectious Disease Journal 15, 1002-8.
17. Wheat, J. (1995). Endemic mycoses in AIDS: a clinical review. Clinical Microbiology Reviews 8, 146-59.
18. Hajjeh, R. A. (1995). Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clinical Infectious Diseases 21 Suppl. 1, S108-10.
19. Lortholary, O., Dupont, B., Meyohas, M. C., Rozenbaum, W., Datry, A., Vinchon, I. et al. (1996). Imported histoplasmosis due to H. capsulatum in HIV-infected patients in France. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA 1996, Abstract 1174, American Society for Microbiology, Washington, DC.
20. Wheat, J., Hafner, R., Korzun, A. H., Limjoco, M. T., Spencer, P., Larsen, R. A. et al. (1995). Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. American Journal of Medicine 98, 336-42.
21. Sharkey-Mathis, P. K., Velez, J., Fetchick, R. & Graybill, J. R. (1993). Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole. Journal of Acquired Immune Deficiency Syndromes 6, 809-19.
22. Wheat, L., Mawhinney, S., Jafner, R. & McKinsey, D. (1994). Fluconazole treatment for histoplasmosis in AIDS. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994, Abstract 1233, p. 103. American Society for Microbiology, Washington, DC.
23. Wheat, J., Marichal, P., Vanden Bossche, H., Le Monte, A. & Connolly, P. (1997). Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrobial Agents and Chemotherapy 41, 410-4.
24. McKinsey, D., Wheat, J., Cloud, G., Gutsch, H., Thomas, C., Wiesinger, B. et al. (1996). Itraconazole is effective primary prophylaxis against systemic fungal infections in patients with advanced HIV infection. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996, Abstract LB9. American Society for Microbiology, Washington, DC.
25. Nightingale, S. D., Cal, S. X., Peterson, D. M., Loss, S. D., Gamble, B. A., Watson, D. A. et al. (1992). Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 6, 191-4.
26. Pottage, J. C., Jr & Sha, B. E. (1991). Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole. Journal of Infectious Diseases 164, 622-3.
27. Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., Van der Horst, C. et al. (1995). A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 332, 700-5.
28. Wheat, J., Hafner, R., Wulfsohn, M., Spencer, P., Squires, K., Powderly, W. et al. (1993). Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 118, 610-6.
29. Norris, S., Wheat, J., McKinsey, D., Lancaster, D., Katz, B., Black, J. et al. (1994). Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. American Journal of Medicine 96, 504-8.
30. Gugnani, H. C., Ezeanolue, B. C., Khalil, M., Amoah, C. D., Ajuiu, E. U. & Oyewo, E. A. (1995). Fluconazole in the therapy of tropical deep mycoses. Mycoses 38, 485-8.
31. Dupont, B., Lortholary, O., Datry, A., Gentilini, M., Vinchon, I. & Guillevin L. (1996). Imported histoplasmosis due to H. duboisii in France (1968-1994). In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996, Abstract K58. American Society for Microbiology, Washington, DC.
32. Stevens, D. A. (1995). Coccidioidomycosis. New England Journal of Medicine 332, 1077-82.
33. Clissold, S. P. (1987). Clinical experience in systemic and subcutaneous mycoses. In Ketoconazole Today: A Review of Clinical Experience, (Jones, H. E., Ed.), pp. 57-76. Manchester.
34. Stevens, D. A., Stiller, R. L., Williams, P. L. & Sugar, A. M. (1983). Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. American Journal of Medicine 74, Suppl. 1B, 58-63.
35. Galgiani, J. N., Stevens, D. A., Graybill, J. R., Dismukes, W. E. & Cloud, G. A. (1988). Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400- and 800-mg doses and observations at higher doses. American Journal of Medicine 84, 603-10.
36. Robinson, P. A., Knirsch, A. K. & Joseph, J. A. (1990). Fluconazole for life-threatening fungal infections in patients who cannot be treated by conventional antifungal agents. Review of Infectious Diseases 12, Suppl. 3, S349-63.
37. Diaz, M., Negroni, R., Montero-Gei, F., Castro, L. G. M., Sampaio, S. A. P., Borelli, D. et al. (1992). A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clinical Infectious Diseases 14, Suppl. 1, S68-76.
38. Catanzaro, A., Galgiani, J. N., Levine, B. E., Sharkey-Mathis, P. K., Fierer, J., Stevens, D. A. et al. (1995). Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. American Journal of Medicine 98, 249-56.
39. Tucker, R. M., Galgiani, J. N., Denning, D. W., Hanson, L. H., Graybill, J. R., Sharkey, K. et al. (1990). Treatment of coccidioidal meningitis with fluconazole. Review of Infectious Diseases 12, Suppl. 3, S380-9.
40. Galgiani, J. N., Catanzaro, A., Cloud, G. A., Higgs, J., Friedman, B. A. & Larsen, R. A. et al. (1993). Fluconazole therapy for coccidioidal meningitis. Annals of Internal Medicine 119, 28-35.
41. Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Diaz, M., Rendon, A., Cloud, G. A. et al. (1996). Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Annals of Internal Medicine 124, 305-10.
42. Perez, J. A. Jr, Johnson, R. H., Caldwell, J. W., Arsura, E. L. & Nemecheck, P. (1995). Fluconazole therapy in coccidioidal meningitis maintained with intrathecal amphotericin B. Archives of Internal Medicine 155, 1665-8.
43. Banuelos, A. F., Williams, P. L., Johnson, R. H., Bibi, S., Fredricks, D. N., Gilroy, S. A. et al. (1996). Central nervous system abscesses due to Coccidioides species. Clinical Infectious Diseases 22, 240-50.
44. Luttrull, J. K., Wan, W. L., Kubak, B. M., Smith, M. D. & Oster, H. A. (1995). Treatment of ocular fungal infections with oral fluconazole. American Journal of Ophthalmology 119, 477-81.
45. Tucker, R. M., Williams, P. L., Arathoon, E. G. & Stevens, D. A. (1988). Treatment of mycoses with itraconazole. Annals of the New York Academy of Science 544, 451-70.
46. Graybill, J. R., Stevens, D. A., Galgiani, J. N., Dismukes, W. E., Cloud, G. A. & others in the NAIAD Mycoses Study Group. (1990). Itraconazole treatment of coccidioidomycosis. American Journal of Medicine 89, 282-90.
47. Diaz, M., Puente, R., de Hoyos, L. A. & Cruz, S. (1991). Itraconazole in the treatment of coccidioidomycosis. Chest 100, 682-4.
48. Tucker, R. M., Denning, D. W., Dupont, B. & Stevens, D. A. (1990). Itraconazole therapy for chronic coccidioidal meningitis. Annals of Internal Medicine 112, 108-12.
49. Kauffman, C. A. (1996). Role of azoles in antifungal therapy. Clinical Infectious Diseases 22, Suppl. 2, S148-53.
50. Kushwaha, V. P., Shaw, B. A., Gerardi, J. A. & Oppenheim, W. L. (1996). Musculoskeletal coccidioidomycosis. A review of 25 cases. Clinical Orthopaedics and Related Research 332, 190-9.
51. Singh, V. R., Smith, D. K., Lawerence, J., Kelly, P. C., Thomas, A. R., Spitz, B. et al. (1996). Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clinical Infectious Diseases 23, 563-8.
52. McNeil, M. M. & Ampel, N. M. (1995). Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clinical Infectious Diseases 21, Suppl. 1, S111-3.
53. Gottlieb, J. L., McAllister, I. L., Guttman, F. A. & Vine, A. K. (1995). Choroidal blastomycosis. A report of two cases. Retina 15, 248-52.
54. Schutze, G. E., Hickerson, S. L., Fortin, E. M., Schellhase, D. E., Darville, T., Gubbins, P. O. et al. (1996). Blastomycosis in children. Clinical Infectious Diseases 22, 496-502.
55. Bradsher, R. W. (1996). Histoplasmosis and blastomycosis. Clinical Infectious Diseases 22, Suppl. 2, S102-11.
56. National Institute of Allergy and Infectious Diseases Mycoses Study Group. (1985). Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. Annals of Internal Medicine 103, 861-72.
57. Pappas, P. G., Bradsher, R. W., Chapman, S. W., Kauffman, C. A., Dine, A., Cloud, G. A. et al. (1995). Treatment of blastomycosis with fluconazole: a pilot study. Clinical Infectious Diseases 20, 267-71.
58. Dismukes, W. E., Bradhser, R. W., Cloud, G. C., Kauffman, C. A., Chapman, S. W., George, R. B. et al. (1992). Itraconazole therapy for blastomycosis and histoplasmosis. American Journal of Medicine 93, 489-97.
59. Sugar, A. M. & Liu, X. P. (1996). In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrobial Agents and Chemotherapy 40, 1314-6.
60. Booker, K. J. (1996). Blastomycosis-induced respiratory failure: the successful application of continuous positive airway pressure. Heart and Lung 25, 384-7,
61. Albert, M. C., Zachary, S. V. & Alter, S. (1995). Blastomycosis of the forearm synovium in a child. Clinical Orthopaedic and Related Research 317, 223-6.
62. Ward, B. A., Parent, A. D. & Raila, F. (1995). Indications for the surgical management of central nervous system blastomycosis. Surgical Neurology 43, 379-88.
63. Brummer, E., Castaneda, E. & Restrepo, A. (1993). Paracoccidioidomycosis: an update. Clinical Microbiology Reviews 6, 89-117.
64. Restrepo, A., Gomez, I., Cano, L. E., Arango, M. D., Gutierrez, F., Sanin, A. et al. (1983). Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience. American Journal of Medicine 74, Suppl. 1B, 48-52.
65. Borelli, D. (1987). A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Reviews of Infectious Diseases 9, Suppl. 1, S57-63.
66. Naranjo, M. S., Trujillo, M., Munera, M. I., Restrepo, P., Gomez, I. & Restrepo, A. (1990). Treatment of paracoccidioidomycosis with itraconazole. Journal of Medical and Veterinary Mycology 28, 67-76.
67. Diaz, M., Negroni, R., Montero-Gei, F., Castro, L. G. M., Sampaio, S. A. P., Borelli, D. et al. (1992). A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clinical Infectious Diseases 14, Suppl. 1, S68-76.
68. Manns, B. J., Baylis, B. W., Urbanski, S. J., Gibb, A. P. & Rabin, H. R. (1996). Paracoccidioidomycosis. Case report and review. Clinical Infectious Diseases 23, 1026-32.
69. Amstalden, E. M., Xavier, R., Kattapuram, S. V., Bertolo, M. B., Swartz, M. N. & Rosenberg, A. E. (1996). Paracoccidioidomycosis of bones and joints. A clinical, radiologic, and pathologic study of 9 cases. Medicine 75, 213-25.
70. Goldani, L. Z. & Sugar, A. M. (1995). Paracoccidioidomycosis and AIDS: an overview. Clinical Infectious Diseases 21, 1275-81.
71. Nishioka, S. de A. (1996). Paracoccidioidomycosis and AIDS. Clinical Infectious Diseases 22, 1132-3.
72. Drouhet, E. & Dupont, B. (1995). Infection due to Penicillium marneffei. systemic mycosis with cutaneous manifestations associated to AIDS. Journal de Mycologie Médicale 5, Suppl. 1, 21 -34.
73. Duong, T. A. (1996). Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clinical Infectious Diseases 23, 125-30.
74. Kauffman, C. A. (1995). Old and new therapies for sporotrichosis. Clinical Infectious Diseases 21, 981-5.
75. Restrepo, A., Robledo, J., Gomez, I., Tabares, A. M. & Gutierrez, R. (1986). Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Archives of Dermatology 122, 413-7.
76. Castro, L. G. M., Belda, W., Jr, Cucé, L. C., Sampaio, S. A. P. & Stevens, D. A. (1993). Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. British Journal of Dermatology 128, 352-6.
77. Kauffman, C. A., Pappas, P. G., McKinsey, D. S., Greenfield, R. A., Perfect, J. R., Cloud, G. A. et al. (1996). Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clinical Infectious Diseases 22, 46-50.
78. Bargman, H. (1995). Successful treatment of cutaneous sporotrichosis with liquid nitrogen. Report of three cases. Mycoses 38, 285-7.
79. Kudoh, K., Kamei, E., Terunuma, A., Nakagawa, S. & Tagami, H. (1996). Successful treatment of cutaneous sporotrichosis with terbinafine. Journal of Dermatological Treatment 7, 33-5.
80. Sharkey-Mathis, P. K., Kauffman, C. A., Graybill, J. R., Stevens, D. A., Hostetler, J. S., Cloud, G. et al. (1993). Treatment of sporotrichosis with itraconazole. American Journal of Medicine 95, 279-85.
81. DeHart, D. J. (1995). Use of itraconazole for treatment of sporotrichosis involving a knee prosthesis. Clinical Infectious Diseases 21, 450.
82. Badley, A. D. & Van Scoy, R. E. (1996). Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole. Clinical Infectious Diseases 23, 394-5.
83. Morgan, M. & Reves, R. (1996). Invasive sinusitis due to Sporothrix schenckii in a patient with AIDS. Clinical Infectious Diseases 23, 1319-20.
84. Yu, R. (1995). Successful treatment of chromoblastomycosis with itraconazole. Mycoses 38, 79-83.
85. Kullavanijaya, P. & Rojanavanich, V. (1995). Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. International Journal of Dermatology 34, 804-7.
86. McGinnis, M. R. (1996). Mycetoma. Dermatologia Clinica 14, 97-104.
87. Welsh, O., Salinas, M. C. & Rodriguez, M. A. (1995). Treatment of eumycetoma and actinomycetoma. Current Topics in Medical Mycology 6, 47-71.
88. Lee, M. W., Kim, J. C., Choi, J. S., Kim, K. H. & Greer, D. L. (1995). Mycetoma caused by Acemonium falciforme: successful treatment with itraconazole. Journal of the American Academy of Dermatology 32, 897-900.